inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester has been researched along with gadolinium in 1 studies
Studies (inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester) | Trials (inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester) | Recent Studies (post-2010) (inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester) | Studies (gadolinium) | Trials (gadolinium) | Recent Studies (post-2010) (gadolinium) |
---|---|---|---|---|---|
46 | 0 | 2 | 13,838 | 519 | 6,282 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aspeslagh, S; Braet, K; Evans, WH; Leybaert, L; Martin, PE; Vandamme, W; Willecke, K | 1 |
1 other study(ies) available for inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester and gadolinium
Article | Year |
---|---|
Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells.
Topics: Adenosine Triphosphate; Animals; Blood-Brain Barrier; Brain; Calcium; Cells, Cultured; Connexin 43; Connexins; Endothelium, Vascular; Extracellular Space; Flufenamic Acid; Gadolinium; Gap Junction beta-1 Protein; Gap Junctions; Glycyrrhetinic Acid; Humans; Inositol 1,4,5-Trisphosphate; Lanthanum; Niflumic Acid; Nitrobenzoates; Oligopeptides; Rats; Ultraviolet Rays | 2003 |